Tibor Pankotai

University of Szeged — Hungary

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.5kcitations82works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(24), Genomics and Chromatin Dynamics(17), Ubiquitin and proteasome pathways(13), RNA Research and Splicing(9), CRISPR and Genetic Engineering(8)

Publications82 total

Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity
Clinical and Translational Medicine·2025· 1 citedOpen Access
Exploring potent miRNA combinations for detecting early-stage breast cancer
Molecular Therapy — Nucleic Acids·2025· 1 citedOpen Access
Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
Journal of Proteome Research·2025· 3 citedOpen Access
The Cause of Most Common Antler Abnormality is Not a Fracture But an Osteomyelitis Like Disease the Pedunculitis Chronica Deformans
2025
Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes
International Journal of Molecular Sciences·2025· 5 citedOpen Access
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes
International Journal of Dermatology·2024· 4 citedOpen Access
Novel biomarkers of mitochondrial dysfunction in Long COVID patients
GeroScience·2024· 22 citedOpen Access
miR-21, miR-29a, and miR-106b: serum and tissue biomarkers with diagnostic potential in metastatic testicular cancer
Scientific Reports·2024· 7 citedOpen Access
Increased DNA damage of adipose tissue-derived mesenchymal stem cells under inflammatory conditions
Heliyon·2024Open Access
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts
Frontiers in Oncology·2024· 5 citedOpen Access
Mitochondrial dysfunction and immune suppression in BRAF V600E‐mutated metastatic melanoma
Clinical and Translational Medicine·2024· 5 citedOpen Access
Prognostic potential of CUL3 ligase with differential roles in luminal A and basal type breast cancer tumors
Scientific Reports·2024· 3 citedOpen Access
LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment
International Journal of Gynecological Pathology·2024· 3 citedOpen Access
Emerging human pulmonary dirofilariasis in Hungary: a single center experience
Diagnostic Pathology·2024· 5 citedOpen Access
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts
2024Open Access
Complex treatment of residual metastatic germ cell cancer: A single center experience
Journal of Biotechnology·2024· 2 citedOpen Access
Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction
2024Open Access
Routine molecular applications and recent advances in breast cancer diagnostics
Journal of Biotechnology·2023· 17 citedOpen Access
Predictive Potential of RNA Polymerase B (II) Subunit 1 (RPB1) Cytoplasmic Aggregation for Neoadjuvant Chemotherapy Failure
International Journal of Molecular Sciences·2023· 5 citedOpen Access
Identifying Suitable Reference Gene Candidates for Quantification of DNA Damage-Induced Cellular Responses in Human U2OS Cell Culture System
Biomolecules·2023· 4 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Zsuzsanna Újfaludi(21), Barbara N. Borsos(19), Imre Boros(16), Zoltán G. Páhi(13), Hajnalka Majoros(12), Orbán Komonyi(7), István Balázs Németh(6), Vasiliki Pantazi(6), Farkas Sükösd(6), Evi Soutoglou(5), Krisztina Buzás(5), Gabriella Pankotai-Bodó(5), Orsolya Oláh‐Németh(5), László Bodai(4), Làszlò Tora(4), Mária Harmati(4), Gabriella Dobra(4), Miklós Erdélyi(4), Nóra Ördög(4), Áron Bartha(4)